Literature DB >> 27957651

Carnosic acid protects non-alcoholic fatty liver-induced dopaminergic neuron injury in rats.

Ting Xu1, Junjun Zhou2, Jie Zhu1, Shuai Zhang1, Ning Zhang1,3, Yan Zhao1, Chunchun Ding1, Xue Shi1, Jihong Yao4.   

Abstract

Non-alcoholic fatty liver disease (NAFLD) has been reported to induce cognitive impairments of hippocampus and may influence central nervous system. In the present study, we investigated whether carnosic acid (CA) ameliorates dopaminergic neuron injury in a rat model of NAFLD. In order to induce NAFLD, rats were fed with high-fat diet (HFD) for 10 weeks. We found that continued CA administration reduced lipid accumulation marked by decreases in alanine aminotransferase (ALT), aspartate aminotransferase (AST), triglyceride (TG), total cholesterol (TC) and low-density lipoprotein cholesterol (LDL-C) levels, and an increase in high-density lipoprotein cholesterol (HDL-C) level in the serum. H&E staining revealed that feeding CA reduced lipid droplets accumulation, and alleviated oxidative stress by increasing in superoxide dismutase (SOD) level and decreasing in malondialdehyde (MDA) level in the liver. In addition, by measuring several parameters of gait analysis, we demonstrated that CA treatment ameliorated behavioral impairments, as evidenced by decreased duration and maximum variation, accompanied by increased average speed and cadence. Furthermore, CA treated-animals displayed an increase in the contents of dopamine (DA) and its metabolites 3,4-dihydroxyphenylacelic acid (DOPAC) and elevated the expressions of tyrosine hydroxylase (TH)-positive neurons in the substantia nigra (SN) as well as the TH protein in the striatum. Together, these findings suggest that CA may be an effective agent in protecting rats from NAFLD-induced dopaminergic neuron injury.

Entities:  

Keywords:  Carnosic acid; Dopaminergic neuron injury; Non-alcoholic fatty liver disease

Mesh:

Substances:

Year:  2016        PMID: 27957651     DOI: 10.1007/s11011-016-9941-8

Source DB:  PubMed          Journal:  Metab Brain Dis        ISSN: 0885-7490            Impact factor:   3.584


  41 in total

1.  Non-alcoholic fatty liver disease impairs hippocampal-dependent memory in male rats.

Authors:  A P Ross; E C Bruggeman; A W Kasumu; J G Mielke; M B Parent
Journal:  Physiol Behav       Date:  2012-01-17

2.  Non-alcoholic fatty liver induces insulin resistance and metabolic disorders with development of brain damage and dysfunction.

Authors:  Doaa A Ghareeb; Hani S Hafez; Hend M Hussien; Nihal F Kabapy
Journal:  Metab Brain Dis       Date:  2011-09-01       Impact factor: 3.584

3.  The progression of Parkinson disease: a hypothesis.

Authors:  Anthony E Lang
Journal:  Neurology       Date:  2007-03-20       Impact factor: 9.910

4.  Enhanced GABA Transmission Drives Bradykinesia Following Loss of Dopamine D2 Receptor Signaling.

Authors:  Julia C Lemos; Danielle M Friend; Alanna R Kaplan; Jung Hoon Shin; Marcelo Rubinstein; Alexxai V Kravitz; Veronica A Alvarez
Journal:  Neuron       Date:  2016-05-18       Impact factor: 17.173

5.  High-fat diet decreases tyrosine hydroxylase mRNA expression irrespective of obesity susceptibility in mice.

Authors:  Yulin Li; Timothy South; Mei Han; Jiezhong Chen; Rui Wang; Xu-Feng Huang
Journal:  Brain Res       Date:  2009-03-11       Impact factor: 3.252

6.  Malondialdehyde, a product of lipid peroxidation, is mutagenic in human cells.

Authors:  Laura J Niedernhofer; J Scott Daniels; Carol A Rouzer; Rachel E Greene; Lawrence J Marnett
Journal:  J Biol Chem       Date:  2003-05-29       Impact factor: 5.157

7.  Synaptic input changes to spinal cord motoneurons correlate with motor control impairments in a type 1 diabetes mellitus model.

Authors:  Suzana Ulian Benitez; Everardo Magalhães Carneiro; Alexandre Leite Rodrigues de Oliveira
Journal:  Brain Behav       Date:  2015-09-09       Impact factor: 2.708

8.  Dietary carnosic acid suppresses hepatic steatosis formation via regulation of hepatic fatty acid metabolism in high-fat diet-fed mice.

Authors:  Mi-Young Park; Seong Taek Mun
Journal:  Nutr Res Pract       Date:  2013-08-07       Impact factor: 1.926

9.  Antioxidant activity of rosemary (Rosmarinus officinalis L.) essential oil and its hepatoprotective potential.

Authors:  Aleksandar Rašković; Isidora Milanović; Nebojša Pavlović; Tatjana Ćebović; Saša Vukmirović; Momir Mikov
Journal:  BMC Complement Altern Med       Date:  2014-07-07       Impact factor: 3.659

10.  New insights into salvianolic acid A action: Regulation of the TXNIP/NLRP3 and TXNIP/ChREBP pathways ameliorates HFD-induced NAFLD in rats.

Authors:  Chunchun Ding; Yan Zhao; Xue Shi; Ning Zhang; Guo Zu; Zhenlu Li; Junjun Zhou; Dongyan Gao; Li Lv; Xiaofeng Tian; Jihong Yao
Journal:  Sci Rep       Date:  2016-06-27       Impact factor: 4.379

View more
  4 in total

1.  Non-alcoholic Fatty Liver Disease: Also a Disease of the Brain? A Systematic Review of the Preclinical Evidence.

Authors:  Anne Catrine Daugaard Mikkelsen; Kristoffer Kjærgaard; Rajeshwar Prosad Mookerjee; Hendrik Vilstrup; Gregers Wegener; Cecilie Bay-Richter; Karen Louise Thomsen
Journal:  Neurochem Res       Date:  2022-03-01       Impact factor: 3.996

2.  Effect of High Fat and Fructo-Oligosaccharide Consumption on Immunoglobulin A in Saliva and Salivary Glands in Rats.

Authors:  Yuko Yamamoto; Toshiya Morozumi; Toru Takahashi; Juri Saruta; Wakako Sakaguchi; Masahiro To; Nobuhisa Kubota; Tomoko Shimizu; Yohei Kamata; Akira Kawata; Keiichi Tsukinoki
Journal:  Nutrients       Date:  2021-04-10       Impact factor: 5.717

Review 3.  Novel insights into non-alcoholic fatty liver disease and dementia: insulin resistance, hyperammonemia, gut dysbiosis, vascular impairment, and inflammation.

Authors:  So Yeong Cheon; Juhyun Song
Journal:  Cell Biosci       Date:  2022-06-28       Impact factor: 9.584

Review 4.  Potential Therapeutic Benefits of Herbs and Supplements in Patients with NAFLD.

Authors:  Brandon J Perumpail; Andrew A Li; Umair Iqbal; Sandy Sallam; Neha D Shah; Waiyee Kwong; George Cholankeril; Donghee Kim; Aijaz Ahmed
Journal:  Diseases       Date:  2018-09-10
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.